MyAverix Finance
US · Healthcare
Rallybio Corp (RLYB)
Biotechnology
Rallybio Corp (RLYB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RLYB
Rallybio Corp (RLYB) — FAQ
What is RLYB's P/E ratio?
The price-to-earnings (P/E) ratio for Rallybio Corp (RLYB) is 25.00 (data as of 2026-05-23).
Does Rallybio Corp pay a dividend?
Dividend yield is not available in the current snapshot for Rallybio Corp (RLYB). Check the MyAverix Finance app for the latest dividend data.
What sector is Rallybio Corp in?
Rallybio Corp (RLYB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RLYB listed on?
RLYB is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.